Versuchen GOLD - Frei
Funding, Lack of Talent Trip Up India's AI Leadership Goal
Mint Chennai
|August 19, 2025
While more AI startups are seeking funds from VC investors, they are still very small in scale
Elusive big-ticket private funding, low research and development (R&D) investments and a shortage of engineers with specialized skills continue to threaten India's ambition to become a global leader in artificial intelligence (AI).
Last week, a report by industry body National Association of Software and Services Companies (Nasscom) said that while more and more AI startups are seeking funds from venture capital investors, they are still very small in scale. In the first six months of this calendar year, 87% of the $122 million invested by VCs in AI startups went into early-stage investments.
Indian ventures, according to the report, raised less than $16 million in late funding in the first six months of this year. In comparison, during the same period, at least 21 AI startups in the US have raised $100 million or more each to scale up development. This is in addition to AI behemoths Anthropic and OpenAI raising billion-dollar rounds. A total of $4.9 billion was raised by the American startups seeking large funds for AI training and scaling, making India's large investments insignificant, if not inconsequential.
Diese Geschichte stammt aus der August 19, 2025-Ausgabe von Mint Chennai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
